ClinicalTrials.gov
ClinicalTrials.gov Menu

Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01966302
Recruitment Status : Active, not recruiting
First Posted : October 21, 2013
Last Update Posted : February 2, 2018
Sponsor:
Collaborator:
Lung Biotechnology PBC
Information provided by (Responsible Party):
ronald oudiz, m.d., Los Angeles Biomedical Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019